Active and passive smoking: hazards for children

R A Etzel1

  • 1National Centre for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Insights

The tobacco industry targets adolescents, while environmental tobacco smoke harms children, causing respiratory issues, ear infections, and increasing risks for SIDS and adult cancers. Pediatricians should limit children

Area of Science:

  • Pediatric Health
  • Environmental Health
  • Tobacco Control

Background:

  • The tobacco industry actively recruits adolescents into smoking.
  • Environmental tobacco smoke (ETS) poses significant health risks to non-smokers, particularly children.
  • Pediatricians play a crucial role in addressing and mitigating smoking behaviors and exposures.

Purpose of the Study:

  • To detail tobacco industry tactics for adolescent recruitment.
  • To outline the adverse health effects of passive smoking on children.
  • To recommend pediatrician interventions for influencing smoking behavior.

Main Methods:

  • Review of tobacco industry strategies targeting youth.
  • Compilation of scientific evidence on ETS health impacts.
  • Identification of pediatrician-led smoking cessation and prevention strategies.

Main Results:

  • Passive smoking causes six distinct health effects in children.
  • Increased lower respiratory illnesses, middle ear effusions, and pulmonary function changes observed in exposed children.
  • ETS exposure is linked to Sudden Infant Death Syndrome (SIDS) and increased adult risks of leukemia and lymphoma.

Conclusions:

  • Environmental tobacco smoke exposure is a critical pediatric health concern.
  • Pediatricians must actively work to minimize children's exposure to secondhand smoke.
  • Interventions are needed to counteract industry recruitment and protect child health from tobacco smoke.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...